Navigation Links
DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV
Date:9/19/2013

VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 19, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma" or "DelMar") today announced a discussion on CEOLIVE.TV by Jeffrey Bacha, president and CEO of DelMar Pharma, a cancer-focused company developing new therapies for patients with little to no treatment options. DelMar's first drug in development is VAL-083, a potential first-in-class treatment for glioblastoma multiforme (GBM). 

Mr. Bacha will also discuss how the company is strategically advancing VAL-083 in the U.S., where the drug is in encouraging Phase I/II clinical trials for glioblastoma, and in China, where the drug is currently approved to treat lung cancer and chronic myelogenous leukemia (CML).

Watch the interview here: http://www.ceolive.tv/delmarpharma

Quotes:

Jeffrey Bacha, president and CEO of DelMar Pharma, "We are testing VAL-083 in glioblastoma, where there is the greatest need and greatest potential impact, and we are running our studies as quickly as possible to get this promising drug into the hands of physicians to treat the patients who need it the most."

Key Facts:

  • More than 15,000 people are diagnosed with glioblastoma each year in the U.S.
  • Approximately half of glioblastoma patients will fail the approved therapies
  • Many patients develop resistance to the front-line therapy, Temodar® ($950 million annual sales), because of an enzyme known as MGMT
  • VAL-083 acts through a mechanism independent of MGMT
  • Interim clinical trial results presented at ASCO suggest VAL-083 may have an improved s
    '/>"/>

SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
10. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
11. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
(Date:7/31/2014)... and VIENNA , July 31, ... a press conference in New York ... a vaccine against Parkinson,s disease. PD01A is the first therapy ... enter clinical testing. The Michael J. Fox Foundation ... 1.5 million grant, and presented at the press conference on ...
(Date:7/31/2014)... and LONDON , July 31, 2014 ... provider for the medical industries, announced today the incorporation of genae ... United Kingdom has one of the largest medical ... billion in 2012 and it is projected to increase by a ... 234 billion in 2012, equal to 9.5% of GDP. Despite recessionary ...
Breaking Medicine Technology:Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4genae Opens Offices in London 2
... NEW YORK, April 14, 2011 Reportlinker.com announces ... in its catalogue: Macular Degeneration ... http://www.reportlinker.com/p0472337/Macular-Degeneration-Therapy-Area-Pipeline-Report.html The Macular Degeneration Therapy ... macular degeneration drug pipeline. This report provides insight ...
... April 13, 2011 RushCard announced today that money-saving ... members.  The plans allow for savings on a variety ... diabetes management products, lab services and more. ... health care offerings, bringing unmatched value to RushCard members. ...
Cached Medicine Technology:Reportlinker Adds Macular Degeneration Therapy Area Pipeline Report 2Reportlinker Adds Macular Degeneration Therapy Area Pipeline Report 3RushCard Offers Members Exclusive Discounts on Health Care Services 2
(Date:7/31/2014)... Miami, FL (PRWEB) July 31, 2014 ... recently released their innovative compression elbow sleeve , ... other elbow pain, in two new bright colors for ... neon pink and blue. Made of innovative proprietary Zensah® ... moisture wicking and odor-preventing fabric. It features a no-slip ...
(Date:7/31/2014)... New York (PRWEB) July 31, 2014 ... whistleblowers in qui tam cases, comments that whistleblowers are ... end to illegal employer activities that may cause harm ... that today is National Whistleblower Appreciation Day. , According ... Whistleblower Center , the Senate declared "National Whistleblower Appreciation ...
(Date:7/31/2014)... 31, 2014 CarePoint Health is ... Masood Rizvi, has joined our network, CarePoint Health ... the community. Hundreds of highly skilled and experienced ... network of top doctors and practices in Hudson ... latest acquisition represents CarePoint Health’s commitment to provide ...
(Date:7/31/2014)... July 31, 2014 You’re having a wonderful ... have you suddenly developed chills and fever, headache, stiff neck, ... suspect a flu-like illness, it could actually be the first ... risk of developing Lyme is greater than you might think. ... cases occurred in the U.S. annually. But the Centers for ...
(Date:7/31/2014)... 2014 Two years in the making, ... overview of the research behind the latest scientific findings ... and Vesanto Melina, well-respected authorities on plant-based nutrition, put ... safe and adequate for people at all stages of ... athletes and pregnant or lactating women. , Well-planned ...
Breaking Medicine News(10 mins):Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 2Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 3Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 2Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 3Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 4Health News:Dr. Rizvi Joins CarePoint Health Medical Group 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 3Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 2Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 3
... 30 The misleading "health" halo surrounding highly-publicized marketing ... , Recent announcements by Starbucks and other brands ... certain products are being called into question in news ... articles have poked holes in companies, marketing efforts and ...
... S.C., June 30 Informatics Corporation of America (ICA) ... (CDS) to offer a solution that integrates with and ... electronic health record. ICA and CDS will offer health ... move clinical information among disparate health care information systems ...
... success, welcoming 1012 visitors who left the show impressed and vowing ... A total success. That sums up ... held for the first time on June 15-16, 2009 at Sao ... over 1000 key decision-makers in the food industry, in this, its ...
... Facilities in Pennsylvania Make Substantial Progress in Reducing Infections ... Pa., June 30 Two hospitals in southeast Pennsylvania ... intensive care patients in their facilities and are featured ... Safety Advisory. , , Patients in intensive ...
... Fla., June 30 JAG Media Holdings, Inc. (OTC Bulletin ... of its acquisition of CardioGenics Inc. by its Ontario, Canada ... currently scheduled for June 30, 2009, has been rescheduled to ... the parties sufficient time to attend to the remaining closing ...
... The Netherlands: Women who have a diminished number of eggs ... some other reason such as ovarian surgery, may be more ... ovarian reserve within the normal, fertile range. Trisomic pregnancies ... rather than the normal two. The most common trisomy is ...
Cached Medicine News:Health News:Recent News Reports of Sweetener Reformulations Raise Questions About Motivations 2Health News:Recent News Reports of Sweetener Reformulations Raise Questions About Motivations 3Health News:ICA, CDS Team Up to Offer Solution That Aggregates Patient Information 2Health News:ICA, CDS Team Up to Offer Solution That Aggregates Patient Information 3Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 2Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 3Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 4Health News:Pennsylvania Patient Safety Authority Releases June Advisory 2Health News:Pennsylvania Patient Safety Authority Releases June Advisory 3Health News:Pennsylvania Patient Safety Authority Releases June Advisory 4Health News:Pennsylvania Patient Safety Authority Releases June Advisory 5Health News:JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc. 2Health News:JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc. 3Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 2Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: